Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Patel Sanj K
Relationship:  
City:   Lexington
State:   MA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   63,012    

Indirect Shares

   109,795      
Direct Value   $1,230,624    

Indirect Value

   $2,144,296      
Total Shares   172,807      
Total Value   $3,374,921      


Kiniksa Pharmaceuticals, Ltd. $1,230,624 Kiniksa Pharmaceuticals, Ltd. $1,230,624
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Synageva BioPharma Corp GEVA President & CEO, Direc... 2015-06-22 0 2015-06-22 0    Premium*  
            Kiniksa Pharmaceuticals, Ltd. KNSA 2024-04-08 63,012 2024-04-08 109,795    Premium*  
* Premium Members only  

Records found :    93         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
GEVA Synageva BioPharma Corp President & CEO   •       •      –    2015-06-05 4 A $0.00 $0 D/D 72,000 73,031 0 -
KNSA Kiniksa Pharmaceuticals, ... Chairman & CEO   •       •      –    2018-05-29 4 A $0.00 $0 D/D 135,889 245,685 0 -
GEVA Synageva BioPharma Corp President & CEO   •       •      –    2012-03-23 4 AS $33.53 $1,676,410 D/D (50,000) 1,031 0 -
GEVA Synageva BioPharma Corp President & CEO   •       •      –    2012-08-31 4 AS $49.88 $757,518 D/D (15,187) 1,031 0 -
GEVA Synageva BioPharma Corp President & CEO   •       •      –    2012-09-04 4 AS $49.36 $2,705,372 D/D (54,813) 1,031 0 -
GEVA Synageva BioPharma Corp President & CEO   •       •      –    2012-11-30 4 AS $48.87 $244,326 D/D (5,000) 1,031 0 -
GEVA Synageva BioPharma Corp President & CEO   •       •      –    2012-12-03 4 AS $49.42 $1,482,492 D/D (30,000) 1,031 0 -
GEVA Synageva BioPharma Corp President & CEO   •       •      –    2012-12-04 4 AS $49.34 $1,134,850 D/D (23,000) 1,031 0 -
GEVA Synageva BioPharma Corp President & CEO   •       •      –    2012-12-05 4 AS $48.10 $577,255 D/D (12,000) 1,031 0 -
GEVA Synageva BioPharma Corp President & CEO   •       •      –    2012-12-13 4 AS $45.12 $657,470 D/D (14,400) 1,031 0 -
GEVA Synageva BioPharma Corp President & CEO   •       •      –    2012-12-14 4 AS $45.30 $601,629 D/D (13,281) 1,031 0 -
GEVA Synageva BioPharma Corp President & CEO   •       •      –    2012-12-17 4 AS $45.97 $1,513,338 D/D (32,319) 1,031 0 -
GEVA Synageva BioPharma Corp President & CEO   •       •      –    2013-02-20 4 AS $49.49 $1,218,505 D/D (24,608) 1,031 0 -
GEVA Synageva BioPharma Corp President & CEO   •       •      –    2013-02-21 4 AS $49.02 $2,225,116 D/D (45,392) 1,031 0 -
GEVA Synageva BioPharma Corp President & CEO   •       •      –    2013-04-03 4 AS $51.09 $852,227 D/D (16,464) 1,031 0 -
GEVA Synageva BioPharma Corp President & CEO   •       •      –    2013-04-04 4 AS $50.12 $1,102,315 D/D (21,931) 1,031 0 -
GEVA Synageva BioPharma Corp President & CEO   •       •      –    2013-04-05 4 AS $50.11 $496,590 D/D (9,910) 1,031 0 -
GEVA Synageva BioPharma Corp President & CEO   •       •      –    2013-04-08 4 AS $49.49 $1,073,686 D/D (21,695) 1,031 0 -
GEVA Synageva BioPharma Corp President & CEO   •       •      –    2013-06-11 4 AS $40.89 $1,212,307 D/D (29,648) 1,031 0 -
GEVA Synageva BioPharma Corp President & CEO   •       •      –    2013-06-12 4 AS $40.48 $1,633,449 D/D (40,352) 1,031 0 -
GEVA Synageva BioPharma Corp President & CEO   •       •      –    2013-07-25 4 AS $48.73 $716,867 D/D (14,711) 18,235 0 -
GEVA Synageva BioPharma Corp President & CEO   •       •      –    2013-07-26 4 AS $47.91 $3,331,548 D/D (69,394) 1,031 0 -
GEVA Synageva BioPharma Corp President & CEO   •       •      –    2013-07-29 4 AS $47.39 $753,264 D/D (15,895) 1,031 0 -
GEVA Synageva BioPharma Corp President & CEO   •       •      –    2014-01-28 4 AS $87.16 $4,531,045 D/D (51,329) 1,031 0 -
GEVA Synageva BioPharma Corp President & CEO   •       •      –    2014-01-29 4 AS $87.19 $4,483,953 D/D (50,971) 1,031 0 -
  93  Records found
  1  2   3   4      
  Page 1 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us